22nd Aug 2018 17:21
Consort Medical plc (the 'Company')
Director/PDMR shareholding
22 August 2018
Consort Medical plc announces that Jonathan Glenn, CEO, has exercised an award over ordinary shares in the Company ('Ordinary Shares') in accordance with the terms of the Consort Medical plc Performance Share Plan (the 'PSP') (the 'Award').
The Award was exercised for nil consideration on 21 August 2018 pursuant to an award made on 10 September 2015.
The exercise of the Award was satisfied out of the Ordinary Shares held in the Consort Medical plc Employee Share Ownership Trust.
Also on 21 August 2018, Mr Glenn disposed of Ordinary Shares at £11.48 per share with part of the net proceeds of the disposal used to cover the tax liabilities associated to the exercise of the Award. Mr. Glenn's resultant interest in the Ordinary Shares of the Company is shown below.
Individual | Director /PDMR | Ordinary Shares exercised under the PSP | Total Ordinary Shares sold
| Total Ordinary shares retained | Total resultant Ordinary Shares held | % of Ordinary Share capital held |
Jonathan Glenn | Director | 48,449 | 48,449 | nil | 165,367 | 0.34 |
The Company was informed of the above transactions by the Consort Medical Employee Share Ownership Trust on 22 August 2018.
Mr Glenn's resultant shareholding of 165,367 Ordinary Shares equates to a 3.7x multiple of his salary (calculated using the exercise share price of £11.48 per share).
Enquiries: Michelle Palmer Assistant Company Secretary 01442 867920
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
|
Jonathan Glenn | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| CEO | |||
b)
| Initial notification /Amendment
| Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| Exercise of Performance Share Plan Award | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
0 | 48,449 | ||||
d)
| Aggregated information | ||||
n/a | |||||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction
| 21 August 2018 | |||
f)
| Place of the transaction
| Off market transaction | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name
|
Jonathan Glenn | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| CEO | |||
b)
| Initial notification /Amendment
| Initial | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Consort Medical plc | |||
b)
| LEI
| 2138001TBP74FD66QT38 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary 10p shares | |||
Identification code | ISIN: GB0000946276 | ||||
b)
| Nature of the transaction
| Sale of Performance Share Plan shares with part of the proceeds of the disposals used to cover the tax liabilities associated with the exercise of the Award | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
£11.48 | 48,449 | ||||
d)
| Aggregated information | ||||
n/a | |||||
- Aggregated volume | |||||
- Price | |||||
e)
| Date of the transaction | 21 August 2018 | |||
f)
| Place of the transaction
| Off market transaction | |||
Related Shares:
CSRT.L